SEC Form 4 · accession 0000891293-15-000011
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP, Global Medical Affairs · Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | S | 6,700 | $1.92 | D | 1,490,789 | D | |
| Common Stock | Mar 20, 2015 | S | 16,200 | $1.93 | D | 1,474,589 | D | |
| Common Stock | Mar 20, 2015 | S | 18,600 | $1.94 | D | 1,455,989 | D | |
| Common Stock | Mar 20, 2015 | S | 2,900 | $1.943 | D | 1,453,089 | D | |
| Common Stock | Mar 20, 2015 | S | 19,600 | $1.95 | D | 1,433,489 | D | |
| Common Stock | Mar 20, 2015 | S | 3,600 | $1.96 | D | 1,429,889 | D | |
| Common Stock | Mar 21, 2015 | F | 93,970 | $1.935 | D | 1,335,919 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a rule 10b5-1 trading plan.
- F2Represents shares withheld by CTIC to satisfy tax withholding obligations on the vesting of restricted stock.